| Company Name: |
T&W GROUP |
| Tel: |
021-61551611 13296011611 |
| Email: |
contact@trustwe.com |
2'-Amino-2'-deoxy-5'-O-(4,4'-dimethoxytrityl)uridine manufacturers
|
| | 2'-Amino-2'-deoxy-5'-O-(4,4'-dimethoxytrityl)uridine Basic information |
| Product Name: | 2'-Amino-2'-deoxy-5'-O-(4,4'-dimethoxytrityl)uridine | | Synonyms: | 2'-Amino-2'-deoxy-5'-O-DMT-uridine;2'-Amino-2'-deoxy-5'-O-(4,4'-dimethoxytrityl)uridine;Uridine, 2'-amino-5'-O-[bis(4-methoxyphenyl)phenylmethyl]-2'-deoxy-;5'-O-dimethoxytrityl-2'-amino-2'-deoxyuridine;2’-amino-2’-deoxy-5’-O-DMTr-uridine;2’-Amino-2’-deoxy-5’-O-(4,4’-dimethoxytrityl)uridine | | CAS: | 174221-86-4 | | MF: | C30H31N3O7 | | MW: | 545.58 | | EINECS: | | | Product Categories: | | | Mol File: | 174221-86-4.mol |  |
| | 2'-Amino-2'-deoxy-5'-O-(4,4'-dimethoxytrityl)uridine Chemical Properties |
| | 2'-Amino-2'-deoxy-5'-O-(4,4'-dimethoxytrityl)uridine Usage And Synthesis |
| Uses | 2′-Amino-5′-O-[bis(4-methoxyphenyl)phenylmethyl]-2′-deoxyuridine is a purine nucleoside analog. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc[1]. | | References | [1] Robak T, Robak P. Purine nucleoside analogs in the treatment of rarer chronic lymphoid leukemias. Curr Pharm Des. 2012;18(23):3373-88. DOI:10.2174/138161212801227005 |
| | 2'-Amino-2'-deoxy-5'-O-(4,4'-dimethoxytrityl)uridine Preparation Products And Raw materials |
|